Welcome to LiVDerm
Where the Constellations of Medical Dermatology and Aesthetics Collide
Led by world-renowned experts in the field, LiVDerm is a comprehensive dermatologic hub where medical professionals educate, collaborate, and engage.
LiVDerm’s mission is to boldly advance higher standards of dermatology care through live and virtual educational offerings, resources for providers, students and patients, and much more.
As a leading source for the latest therapies, technologies, procedures, and practice guidelines in medical and aesthetic dermatology, LiVDerm empowers providers to manage dermatologic conditions with confident authority. With a multipronged focus on the myriad specialties within the field, LiVDerm provides innovative and integrated education across the dermatology spectrum.
Upcoming Live Events
Complimentary Continuing Education
Alopecia Areata
Interactive Monograph
JAK is Out of the Box: Leveling Up Care for Severe Alopecia Areata Across Patient Populations
Chronic Urticaria
Clinical Brief
Addressing Unmet Needs and Disease Burden in Chronic Spontaneous Urticaria: A Clinical Escape Room Challenge
Chronic Urticaria
Interactive Monograph
Scratching the Surface of BTK Inhibition for Chronic Spontaneous Urticaria Beyond Skin Deep
Atopic Dermatitis
Enduring Webcast
Expanding the Therapeutic “AHR”senal for Pediatric Atopic Dermatitis
Seborrheic Dermatitis
Enduring Webcast
Advances in Non-Steroidal Topicals: PDE-4 Inhibitors for Seborrheic Dermatitis and Beyond
LivDerm Articles
Artificial Intelligence in Dermatology: Enhancing Skin Cancer Detection
The integration of artificial intelligence into dermatology is revolutionizing the early detection and diagnosis of skin cancers. Recent advancements suggest that AI can serve as…
FDA Issues Alert on Risks Associated with Compounded Topical Finasteride
The U.S. Food and Drug Administration (FDA) recently issued an alert regarding compounded topical finasteride products, warning health care providers, compounders, and consumers about potentially…
FDA Approves ZEVASKYN™ for Recessive Dystrophic Epidermolysis Bullosa
The U.S. Food and Drug Administration (FDA) has approved ZEVASKYN™ (prademagene zamikeracel), marking a historic milestone as the first and only autologous cell-based gene therapy…
Allergan Unveils Skin Quality Index to Improve Patient-Provider Communication
Allergan Aesthetics, an AbbVie company, has announced the launch of an innovative Skin Quality Index—a universal vocabulary for skin quality designed to improve patient-provider communication…
Global Dermatological Group Issues Warning on Topical Corticosteroid Misuse in Skin Bleaching Products
The International League of Dermatological Societies (ILDS) recently published an updated position statement addressing the concerning rise in the misuse of topical corticosteroids as skin-bleaching…
Study Links Obesity to Reduced Biologic Efficacy in Psoriasis Treatment
A recent study has identified obesity as a significant contributor to the reduced long-term efficacy of biologic therapies in patients with severe plaque psoriasis, highlighting…
Molecular Instruments and Yale Researchers Unveil Breakthrough in Skin Disease Diagnostics
Molecular Instruments®, Inc. (MI), a leading innovator in bioimaging, has announced a major breakthrough in skin disease diagnostics. In collaboration with the Department of Dermatology…
Understanding Chronic Hand Eczema: New Survey By LEO Pharma and Ipsos
Chronic hand eczema (CHE) is an often-overlooked skin condition that affects nearly 15.9 million people in the United States. Despite its prevalence, many healthcare providers…
FDA Findings of Benzene Contamination in Benzoyl Peroxide Acne Products
During a recent investigation, the U.S. Food and Drug Administration (FDA) conducted testing on 95 acne products containing benzoyl peroxide to assess potential benzene contamination.…
L'Oréal Recalls Acne Treatment Due to Benzene Concerns
L’Oréal has voluntarily recalled all lots of its acne treatment, Effaclar Duo, in the U.S. due to concerns that the product may be contaminated with…
Preventing Post-Inflammatory Hyperpigmentation in Skin of Color: A Systematic Review
Research has shown that individuals with darker Fitzpatrick skin types (III-VI) face a higher risk of developing post-inflammatory hyperpigmentation (PIH). According to studies, this increased…
FDA Clears Investigational New Drug Application for Zabalafin Hydrogel for Atopic Dermatitis
Alphyn has announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug Application (IND) for Zabalafin Hydrogel, a groundbreaking treatment…
Breakthrough in Bullous Pemphigoid Treatment: FDA Fast-Tracks Dupixent sBLA
A potential new treatment for bullous pemphigoid (BP) is on the horizon as the U.S. Food and Drug Administration (FDA) grants priority review to Dupixent’s…
Galderma Trial Reveals Promising Results for Restoring Facial Volume After Weight Loss with Combination Treatment
Galderma recently announced the results of its clinical trial exploring the benefits of combining Restylane® Lyft™ or Contour™ with Sculptra® in patients experiencing facial volume…
New Treatment Shows Promise for Adolescent CHE
DELTA TEEN is a phase 3 clinical trial by LEO Pharma that evaluated Anzupgo® (delgocitinib) 20mg/g cream for adolescents with moderate-to-severe chronic hand eczema (CHE).…
Baricitinib and Narrowband UV-B: Promising Results from a Phase 2 Study on Severe Vitiligo
During a recent phase 2 study, researchers revealed that a combination of baricitinib and narrowband UV-B therapy significantly improved both disease activity and quality of…
FDA Clears Fesarius Therapeutics’ DermiSphere hDRT for Wound Care
Fesarius Therapeutics Inc. recently announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its DermiSphere Hydrogel Dermal Regeneration Template (DermiSphere…
A Growing Trend: Survey Explores Cosmetic Procedures in Pediatric Dermatology
Although cosmetic treatments have traditionally been geared more towards the adult population, current data reveals a growing trend in cosmetic procedures among pediatric patients. This…
Axolotl's Potential in Skin Regeneration: A Breakthrough for Medicine
Research conducted over the years has led to the discovery of the axolotl salamanders (Ambystoma mexicanum) and their remarkable regenerative abilities. These findings offer promising…
Bristol Myers Squibb Announces Positive Topline Results in Phase 3 Sotyktu Trials
In a recent press release, Bristol Myers Squibb announced the positive results of their pivotal Phase 3 trials (POETYK PsA-1 and POETYK PsA-2) evaluating the…
LivDerm Podcasts
IL 31 Mechanism of Action and Clinical Implications for Prurigo Nodularis
Achieving More: How and When to Switch Systemic Therapies in Atopic Dermatitis?
Exploring the Latest Updates in the Epidermolysis Bullosa Treatment Landscape
Exposing the Epidermolysis Bullosa Patient Burden and Challenges in Disease Management
Examining the Gaps and Challenges in Diagnosing and Treating Prurigo Nodularis
Skirting Steroids in Atopic Dermatitis: New Therapies and Expert Strategies for Long-term Control
Choosing the Right Path: JAK Inhibitors or Biologics for Atopic Dermatitis?
Skirting Steroids in Atopic Dermatitis: Dangers and Side Effects of Steroid Exposure in Treatment of AD
Setting the Stage: Effective Onboarding of your AD Patients onto JAK Inhibitor Therapy
The Quest for Itch-Free, Clear Skin in Atopic Dermatitis: New Practice-Informing Evidence
Targeted Intervention for Hidradenitis Suppurativa: Defining Window of Opportunity for Moderate-to-Severe Patients
Psoriasis in Skin of Color Unplugged: Patient and Disease Advocacy
Psoriasis in Skin of Color Unplugged: Advancing Diversity and Inclusion in Clinical Trials
Psoriasis in Skin of Color Unplugged: Gaps in Diagnosis and Dermatologist Training
Psoriasis in Skin of Color Unplugged: Disparities and Access to Care
The Spectrum of Atopic Dermatitis and the Emerging Role of JAK Inhibitors
Updates in JAK Inhibitor Therapies for Alopecia Areata with Brett King, MD
Nuanced Treatment of Pediatric Alopecia Areata with Brittany Craiglow, MD
Navigating the Expanding Treatment Landscape for Pediatric Patients with Atopic Dermatitis
Pearls for Early and Accurate Diagnosis of Infantile Atopic Dermatitis
Improving Communication and Shared Decision-Making with Caregivers of Patients with Atopic Dermatitis
The New Kids on the Block: IL-13 Inhibitors for the Treatment of Moderate-to-Severe Atopic Dermatitis
The New Kids on the Block: IL-13 Inhibitors for the Treatment of Moderate-to-Severe Atopic Dermatitis
Dermatologic Care in the Sexual and Gender Diverse Patient with Klint Peebles, MD
The Latest Advances in Cosmetic Dermatology with Doris J. Day, MD
The Latest Advances with Energy-Based Devices and Scar Treatments with Michael H. Gold, MD, FAAD
Anatomy Matters: The Cadaver Lab Experience with Z. Paul Lorenc, MD
Finding the Fountain of Youth: How Light Keeps Your Skin Glowing
Connect With Us
Looking for more information on our educational opportunities? Please fill out the form below to be contacted by one of our education advisors.
